Background: Stroke reduction with direct oral anticoagulants (DOACs) in atrial fibrillation
(AF) is dependent on adherence and persistence in the real-world setting. Individual study …

Aims Studies on adherence and persistence with non-vitamin K oral anticoagulant (NOAC)
treatment have relied on data from the early years of NOAC availability. We aimed to study …

Introduction Adherence to non-vitamin-K oral anticoagulants (NOACs) may be lower than to
vitamin K antagonists because NOACs do not require routine monitoring. Objective We …

Anticoagulant therapy represents a pivotal element that strongly influences the
thromboembolic risk of non-valvular atrial fibrillation (NVAF) subjects. The main purpose of …

Aims The purpose of this study was to describe adherence with non-vitamin K antagonists
(NOACs) and vitamin K antagonists (VKA) in patients with non-valvular atrial fibrillation …

Introduction: This article aims to compare medication adherence and persistence between
warfarin and direct oral anticoagulants (DOACs) and identify reported adherence barriers …

Aim Low adherence to cardiovascular medications is often difficult to monitor and is
associated with adverse outcomes. We investigated whether there is a difference between …

Background Nonadherence to oral anticoagulants (OACs) is a challenge to stroke risk
reduction in patients with nonvalvular atrial fibrillation (NVAF). Data on primary medication …

Background Evidence of adherence and persistence patterns in anticoagulation (AC)
therapy comparing treatment‐naïve and non‐naïve patients is lacking. The objective of this …

Background Nonadherence to direct oral anticoagulants to prevent stroke occurs in up to
40% of atrial fibrillation patients. Underlying reasons are poorly understood. Objectives This …